Tom Van Blarcom, PhD, on Bringing CAR-T Constructs From Oncology to B-Cell Driven Autoimmune Disease
The senior vice president and head of research at Kyverna Therapeutics discussed the company’s investigational CAR-T therapies, KYV-101 and KYV-201.
Tom Van Blarcom, PhD
Advertisement
Articles by Tom Van Blarcom, PhD
Advertisement
Latest Updated Articles
Tom Van Blarcom, PhD, on Bringing CAR-T Constructs From Oncology to B-Cell Driven Autoimmune DiseasePublished: December 1st 2023 | Updated:
